Non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli strains: Epidemiological significance and microbiological diagnosis

World Journal of Microbiology and Biotechnology

Volumn 16, Issue 8-9, 2000, Pages 711-718

  Bielaszewska, Martina ^a,b   Karch, Helge ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Continental Europe; Diarrhoea; Epidemiology; Haemolytic uremic syndrome; Microbiological diagnosis; Shiga toxin; Shiga toxin producing E. coli non O157; Shiga toxin producing E. coli O157; Sorbitol fermenting Shiga toxin producing Escherichia coli

Indexed keywords

BACTERIUM DETECTION; CLONE; DIARRHEA; EUROPE; FECES ANALYSIS; FERMENTATION; GENETIC STRAIN; HEMOLYTIC UREMIC SYNDROME; MOLECULAR ANALYSIS; SEROGROUP; SEROTYPE; SHIGA TOXIN; SORBITOL; STRAIN DIFFERENCE; VEROTOXIN;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0034461349     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008972605514     Document Type: Article

References (65)

1. Which Shiga toxin-producing types of E. coli are important?
2. Escherichia coli and the hemolytic uremic syndrome
3. Prevalence and clinical manifestation of Shiga-like toxin-producing Escherichia coli infections in Austrian children
4. -
5. A prospective study of Shiga-like toxin-associated diarrhoea in a pediatric population
6. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli
7. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome and diarrhea in the Czech Republic
8. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic
9. Isolation and characterization of sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H- strains in the Czech Republic
10. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome
11. Brote de gastroenteritis asociado con un Escherichia coli verotoxigenico O111:H- VT1 + eae+
12. Zur aktuellen Bedeutung der enterohämorrhagischen Escherichia coli (EHEC) in Deutschland (1994-1995)
13. Infektionen des Menschen durch enterohämorrhagische Escherichia coli (EHEC) in Deutschland, 1996
14. Zur Situation der Infektionen des Menschen durch enterohämorrhagische Escherichia coli (EHEC) in Deutschland, 1997
15. Shiga-like toxin-producing Escherichia coli in Seattle children: A prospective study
16. Possible person-to-person transmission of Escherichia coli O111-associated hemolytic uremic syndrome
17. Occurence and phenotypic properties of verotoxin-producing Escherichia coli in sporadic cases of gastroenteritis
18. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli
19. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe
20. Epidemiology of Shiga toxin-producing Escherichia coli infections in continental Europe
21. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR
22. Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21-Helena, Montana, 1994
23. Infrequent finding of verotoxin-producing Escherichia coli in diarrheal stools in Belgrade, Serbia
24. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France
25. Cluster of cases of haemolytic uraemic syndrome due to unpasteurised cheese
26. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin
27. Construction of recombinant Shiga-like toxin IIv (SLT-IIv) and its use in monitoring the SLT-IIv antibody status of pigs
28. Identification and characterisation of Escherichia coli strains if O157 and non-O157 serogroups containing three distinct Shiga toxin genes
29. The role of enterohaemorrhagic Escherichia coli serotypes other than O157:H7 as causes of disease
30. Hemolytic uremic syndrome due to Shiga-like toxin-producing Escherichia coli O48:H21 in South Australia
31. Epidemiology of Shiga toxin-producing Escherichia coli infections in humans in the United States
32. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome
33. Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: Comparison with DNA probes
34. Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin
35. Growing concerns and recent outbreaks involving non-O157:H7 serotypes of verotoxigenic Escherichia coli
36. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay
37. Evaluation of oligonucleotide probes for identification of Shiga-like-toxin-producing Escherichia coli
38. Hämolytisch-urämisches syndrom bei kleinkindern durch verotoxin-produzierende Escherichia coli
39. -
40. Shiga toxin-producing Escherichia coli infections in Germany
41. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections
42. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
43. Shiga toxin-producing Escherichia coli in Finland from 1990 through 1997: Prevalence and characteristics of isolates
44. Epidemiological surveys on verocytotoxin-producing Escherichia coli in Japan
45. Hemolytic uremic syndrome and diarrhoea in Argentine children: The role of Shiga-like toxins
46. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis
47. Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France
48. Recent outbreaks of infections caused by Escherichia coli O157:H7 in Japan
49. Epidemiology of sporadic diarrhea due to verocytotoxin -producing Escherichia coli: A two-year prospective study
50. Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospital
51. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli
52. Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin
53. Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples
54. Identification of a new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates
55. A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome
56. Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls
57. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933
58. Non-O157 pathogenic Shiga toxin-producing Escherichia coli: Phenotypic and genetic profiling of virulence traits and evidence for clonality
59. A new Shiga toxin variant (Stx2f) from Escherichia coli isolated from pigeons
60. Shiga toxin (verocytotoxin)-producing Escherichia coli in the United Kingdom
61. Escherichia coli O157:H7: Clinical, diagnostic, and epidemiological aspects of human infection
62. Perspective: The problem of non-O157 Shiga toxin (verocytotoxin)-producing Escherichia coli
63. Verocytotoxin-producing Escherichia coli infections in patients with hemolytic uremic syndrome and their family members in the Netherlands
64. Zoonotic non-O157 Shiga toxin-producing Escherichia coli (STEC)
65. Molecular characterization and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains